FDA Brief

Company record

Dixon Investments Inc. dba ARI

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Dixon Investments Inc. dba ARI.

Warning letters

  1. Dixon Investments Inc. dba ARI

    FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.

    High risk